NCT01241682View on ClinicalTrials.gov

Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2012

Conditions
Malignant (Pleural) Mesothelioma
Interventions
BIOLOGICAL

DC + CTX

3x 50x10e6 DC + cyclophosphamide

Trial Locations (1)

3000 CA

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER